ARTICLE | Company News
Advanced Viral other research news
March 1, 1999 8:00 AM UTC
ADVR said that its Reticulose compound decreased the number of cellular CCR5 chemokine receptors on CD4 T lymphocytes. The company suggested that interference with the CCR5 receptor could increase re...